Takamitsu Morikawa

Statistics

Publications

Citations

H-Index

Active since

2013

Affiliations

Takamitsu Morikawa is an author at Fujita Health University specializing in tyrosine kinase inhibitor therapy, tumor vasculature normalization, and renal malignancy.

Publications per year

2013–2024

Publications

Tyrosine kinase inhibitor‐induced vasculopathy in clear cell renal cell carcinoma: an unrecognized antitumour mechanism

Toyonori Tsuzuki, Naoto Sassa, Yoshie Shimoyama et al. · Histopathology · 2013 · 15 citations

Medicine, Oncology, Pharmacology +16

Third nationwide surveillance of bacterial pathogens in patients with acute uncomplicated cystitis conducted by the Japanese surveillance committee during 2020 and 2021: Antimicrobial susceptibility of Escherichia coli, Klebsiella pneumoniae, and Staphylococcus saprophyticus

Koichiro Wada, Ichiro Tsuboi, Satoshi Takahashi et al. · Journal of Infection and Chemotherapy · 2024 · 13 citations

Veterinary Medicine, Infectious Diseases, Microbiology +17

1–2 of 2